Compare Jakarta Setiabudi Internasional Tbk (JSPT) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jakarta Setiabudi Internasional Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Jakarta Setiabudi Internasional Tbk trades at Rp1,415 (market cap 3.25T, 7.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Jakarta Setiabudi Internasional Tbk is far larger — about 19.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (96.7K versus 7.5K). Which is the better fit depends on your goals.
| JSPT | OBAT | |
|---|---|---|
Market Cap | 3.25T | 167.37B |
Volume | 7.5K | 96.7K |
Lot | 75 | 967 |
Turnover | 10.56M | 23.82M |
Average Price | 1,408 | 246.34 |
Value | 10.56M | 23.82M |
Indicative Equilibrium Price | — | 248 |
Indicative Equilibrium Volume | — | 41 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jakarta Setiabudi Internasional Tbk
PT. Jakarta Setiabudi Internasional Tbk (the Company) was established in the Republic of Indonesia within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amended by Law No. 12 year 1970 based on Notarial Deed No. 4 dated July 2, 1975 of Imas Fatimah, S.H., as amended by Notarial Deed No. 15 dated September 11, 1975 of the same notary. At the first time until 1996 this company was focusing in construction. Leasing and office building maintanance and apartment surrounding Kuningan area, Jakarta.
Read more on JSPT →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
